Zum Inhalt springen
Home » CENTOGENE Reports Full Year 2023 Financial Results

CENTOGENE Reports Full Year 2023 Financial Results

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, May 15, 2024 (GLOBE NEWSWIRE) — Centogene N.V. (Nasdaq: CNTG) (“we” or the “Company”), the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today announced financial results for the fiscal year ended December 31, 2023, and provided a business update.

CENTOGENE Reports Full Year 2023 Financial Results and Recent Business Highlights